581 related articles for article (PubMed ID: 19619577)
1. Preparedness for an anthrax attack.
Franz DR
Mol Aspects Med; 2009 Dec; 30(6):503-10. PubMed ID: 19619577
[TBL] [Abstract][Full Text] [Related]
2. [Update on biological weapons and bioterrorism. Important that health services pay attention to unusual events].
Roffey R; Lantorp K; Tegnell A; Elgh F
Lakartidningen; 2001 Dec; 98(50):5746-8, 5751-2. PubMed ID: 11789096
[TBL] [Abstract][Full Text] [Related]
3. [Anthrax--continuous threat to humans and animals].
Mizak L
Przegl Epidemiol; 2004; 58(2):335-42. PubMed ID: 15517814
[TBL] [Abstract][Full Text] [Related]
4. [Anthrax--the Swedish perspective].
Tegnell A; Hellers M; Wollin R; Eriksson U; Forsman M; Engstrand L; Elgh F
Lakartidningen; 2001 Dec; 98(50):5742-5. PubMed ID: 11789095
[TBL] [Abstract][Full Text] [Related]
5. Prevention of inhalational anthrax in the U.S. outbreak.
Brookmeyer R; Blades N
Science; 2002 Mar; 295(5561):1861. PubMed ID: 11884746
[No Abstract] [Full Text] [Related]
6. Anthrax as a biological weapon: an old disease that poses a new threat.
Tasota FJ; Henker RA; Hoffman LA
Crit Care Nurse; 2002 Oct; 22(5):21-32, 34; quiz 35-6. PubMed ID: 12382615
[No Abstract] [Full Text] [Related]
7. Preparedness for a bioterrorism event in Alaska. Part 1: Detection and identification of a biologic event.
Funk EA
Alaska Med; 2000; 42(4):101-13. PubMed ID: 14593880
[TBL] [Abstract][Full Text] [Related]
8. Responding to the threat of bioterrorism: a microbial ecology perspective--the case of anthrax.
Atlas RM
Int Microbiol; 2002 Dec; 5(4):161-7. PubMed ID: 12497181
[TBL] [Abstract][Full Text] [Related]
9. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
Mayer TA; Morrison A; Bersoff-Matcha S; Druckenbrod G; Murphy C; Howell J; Hanfling D; Cates R; Pauze D; Earls J
Clin Infect Dis; 2003 May; 36(10):1275-83. PubMed ID: 12746773
[TBL] [Abstract][Full Text] [Related]
10. [The anthrax bacterium--a biological masterpiece with deadly potential].
Myhre EB
Lakartidningen; 2002 Feb; 99(6):484-7. PubMed ID: 11881219
[No Abstract] [Full Text] [Related]
11. A bacteriolytic agent that detects and kills Bacillus anthracis.
Schuch R; Nelson D; Fischetti VA
Nature; 2002 Aug; 418(6900):884-9. PubMed ID: 12192412
[TBL] [Abstract][Full Text] [Related]
12. Inhalational anthrax.
Cuneo BM
Respir Care Clin N Am; 2004 Mar; 10(1):75-82. PubMed ID: 15062228
[TBL] [Abstract][Full Text] [Related]
13. Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.
Bouzianas DG
Expert Rev Anti Infect Ther; 2007 Aug; 5(4):665-84. PubMed ID: 17678429
[TBL] [Abstract][Full Text] [Related]
14. Bacillus anthracis contamination and inhalational anthrax in a mail processing and distribution center.
Sanderson WT; Stoddard RR; Echt AS; Piacitelli CA; Kim D; Horan J; Davies MM; McCleery RE; Muller P; Schnorr TM; Ward EM; Hales TR
J Appl Microbiol; 2004; 96(5):1048-56. PubMed ID: 15078521
[TBL] [Abstract][Full Text] [Related]
15. Technological advancements for the detection of and protection against biological and chemical warfare agents.
Eubanks LM; Dickerson TJ; Janda KD
Chem Soc Rev; 2007 Mar; 36(3):458-70. PubMed ID: 17325785
[TBL] [Abstract][Full Text] [Related]
16. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
Doolan DL; Freilich DA; Brice GT; Burgess TH; Berzins MP; Bull RL; Graber NL; Dabbs JL; Shatney LL; Blazes DL; Bebris LM; Malone MF; Eisold JF; Mateczun AJ; Martin GJ
J Infect Dis; 2007 Jan; 195(2):174-84. PubMed ID: 17191162
[TBL] [Abstract][Full Text] [Related]
17. Risk of deliberately induced anthrax outbreak.
Ala'Aldeen D
Lancet; 2001 Oct; 358(9291):1386-8. PubMed ID: 11705480
[No Abstract] [Full Text] [Related]
18. [Anthrax].
Calza L; Manfredi R; Chiodo F
Recenti Prog Med; 2001 Dec; 92(12):717-26. PubMed ID: 11822090
[TBL] [Abstract][Full Text] [Related]
19. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
[TBL] [Abstract][Full Text] [Related]
20. [Anthrax].
Bol P
Ned Tijdschr Tandheelkd; 2003 May; 110(5):198-9. PubMed ID: 12784517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
